Renovos develops innovative regenerative medicine technologies using a unique synthetic nanoclay biomaterial for bone augmentation in fracture repair and tissue regeneration
Nanoclay Platform Technology
For decades clay particles have been used in tablets to control drug release through their ability to bind biological molecules. Localisation of these is essential to directing the activity of stem cells. However, conventional injectable gel materials are often poor at retaining these biological signals at the site of injury – they can hold and deliver cells, but the molecules that stimulate the cells diffuse away.
Renovos solves this problem by developing a series of injectable nanoclay matrices for the delivery of proteins and cells or other drugs and biologics for regenerative medicine.
Nanoclay gels have the ability to bind various biological molecules allowing the formation of injectable tissues that form in the body to regenerate sites of injury or disease.
Our nanoclay ensures localised concentration and release of active ingredients, enhancing safety and efficacy of biological agents for regeneration.
About Renovos’ proprietary Nanoclay technologies:
Safety of biologics – reduced ectopic and/or non-specific effects
Efficacy of biologics – sustained localised concentrations, preserved bioactivity
Cost reduction – reduced doses by an order of magnitude through improved localisation and efficacy
Ease of use – clay particle self-assembly allows for minimally invasive, injectable delivery and in-situ gelation
Customisable – allowing for co-delivery of agents and spatial complexity through simple mixing procedures
30-year history of use in cosmetics and toothpaste formulations
Collaborate with us
These properties make our nanoclay formulations applicable to a variety of applications. Renovos welcomes enquiries from potential partners with an interest in one of Renovos’ in house development programmes or wishing to utilise our technologies in their own R&D.
Please get in touch to discuss your requirements. Contact us >